NBBTF News Today: Stay Updated with the Latest Natural Beauty Bio-Technology Limited News in Real Time
Find NBBTF news now at Meyka AI. Stay informed with the latest{" "} Natural Beauty Bio-Technology Limited stocks updates, including price news, market analysis, and expert insights.
Hardwyn India Announces 2:5 Bonus Share Issue, June 10
Hardwyn India proposes 2:5 bonus share issue. Shareholders receive 2 bonus shares per 5 held. Stock rises 0.65% to ₹24.59. Approval vote July 3, 2026.
Lufthansa Adds ITA Airways to Europe-Japan Joint Venture, June 10
Lufthansa adds ITA Airways to Europe-Japan joint venture with ANA, effective autumn 2026. Agreement signed June 8 at IATA meeting in Rio.
Elon Musk Nears $1 Trillion Net Worth as SpaceX IPO Launches June 12
Elon Musk’s net worth approaches $1 trillion as SpaceX IPO launches June 12 with $1.8T valuation and combined stakes exceeding $1.1 trillion.
Solana USD Bounces 1.28% Daily: SOLUSD at $71.94 Target
Solana USD trades at $64.27 with 1.28% daily bounce. Technical analysis shows oversold RSI at 29.24 and strong ADX trend at 28.73.
Germany and France End €100B Fighter Jet Project, June 09
Germany and France cancel €100 billion FCAS fighter jet project after Airbus-Dassault leadership disputes. Combat Cloud may continue separately.
TELUS Stock Falls 0.8% as Dividend Yield Attracts Income Investors, June 09
TELUS stock at C$17.04 offers 9.8% dividend yield with C$20.27 analyst target. Meyka rates B- citing high debt concerns.
Ambani’s Reliance Invests in Trump-Backed Texas Refinery, June 09
Reliance Industries invests in Texas refinery startup backed by Trump Jr., strengthening U.S.-India business ties.
Zentia Collapses Into Administration With 170 Job Losses, June 09
Zentia Limited, historic Gateshead ceiling manufacturer, entered administration with 170 job losses due to high energy prices and weak sales.
SpaceX IPO Set for June 12 at $135 per Share, $1.77T Valuation
SpaceX IPO launches June 12 at $135/share, valuing the company at $1.75T. Largest IPO ever, though analysts warn of overvaluation risks.